About
Technology
Issues
FAQ
Links
Official Page
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.